| Financial Year |
March 31 2023 |
| Monetary Funds |
122,676,193.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
59,632,113.04 |
| Accounts Receivable |
502,503,652.86 |
| Advances to Suppliers |
21,978,199.86 |
| Other Receivables |
15,310,998.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
421,285,575.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,335,631.67 |
| Total Current Assets |
1,243,353,368.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,088,099.83 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
271,597,565.70 |
| Under-construction Projects |
128,201,312.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,883,468.58 |
| R&D expenses |
-- |
| Goodwill |
35,200,461.28 |
| Long-Term Deferred and Prepaid Expenses |
8,795,931.96 |
| Deferred Income Tax Assets |
27,071,532.84 |
| Other Non-Current Assets |
3,583,192.87 |
| Sub-Total of Non-Current Assets |
539,582,848.74 |
| Total Assets |
1,782,936,217.03 |
| Short-Term Loans |
267,801,349.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
146,148,631.21 |
| Accounts Payable |
360,108,180.69 |
| Accounts Received In Advance |
735,126.76 |
| Employee Compensation Payable |
19,355,903.39 |
| Taxes Payable |
6,535,243.65 |
| Interest Payable |
-- |
| Dividend Payable |
1,052,000.00 |
| Other payables |
9,086,207.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,227,486.43 |
| Other Current Liabilities |
51,432,339.03 |
| Sub-Total of Current Liabilities |
1,031,836,901.11 |
| Long-term Loans |
56,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,531,396.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
456,419.53 |
| Deferred Income Tax Liabilities |
396,767.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
114,720,988.61 |
| Total Liabilities |
1,146,557,889.72 |
| Paid-In Capital(Or Share Stock) |
367,654,697.00 |
| Capital Surplus |
1,125,082,826.35 |
| Surplus Reserve |
33,809,196.24 |
| LESS:Treasury Stock |
5,003,122.00 |
| Undistributed Profits |
-891,639,634.72 |
| Minority Stockholder's Interest |
7,508,974.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
628,869,352.88 |
| Owner's Equity（Stockholder's Equity） |
636,378,327.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,782,936,217.03 |
